Dyfyniad APA

Ramalingam, S. S., Harvey, R. D., Saba, N., Owonikoko, T. K., Kauh, J., Shin, D. M., . . . Khuri, F. R. (2010). Phase I and pharmacokinetic study of everolimus, an mTOR inhibitor, in combination with docetaxel for recurrent/refractory non-small cell lung cancer.

Dyfyniad Arddull Chicago

Ramalingam, Suresh S., et al. Phase I and Pharmacokinetic Study of Everolimus, an MTOR Inhibitor, in Combination With Docetaxel for Recurrent/refractory Non-small Cell Lung Cancer. 2010.

Dyfyniad MLA

Ramalingam, Suresh S., et al. Phase I and Pharmacokinetic Study of Everolimus, an MTOR Inhibitor, in Combination With Docetaxel for Recurrent/refractory Non-small Cell Lung Cancer. 2010.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.